News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Final pre-spectified overall survival analysis of CLEAR, a phase III study – summarized by Yuksel Urun
Photo from Yuksel Urun/X
Apr 14, 2024, 10:45

Final pre-spectified overall survival analysis of CLEAR, a phase III study – summarized by Yuksel Urun

Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared on X:

“Final pre-specified Overall Survival Analysis of CLEAR, a Phase III Study:

  • Final CLEAR trial results: Lenvatinib and Pembrolizumab reduces mortality risk by 21% versus Sunitinib in advanced RCC.
  • While median OS is similar, the combo’s lower HR and tight 95% CI underscore its robust benefit over time.
  • Medians are just midpoints; consistent benefit and CI (Confidence Interval) matter most?

Any insights from the statistical point?”Final pre-spectified overall survival analysis of CLEAR, a phase III study - summarized by Yuksel Urun

Additional information.
Source: Yuksel Urun/X

cancer cancer care Cancer research Clear trial Lenvatinib OncoDaily Oncology pembrolizumab Research sunitinib versus Yüksel Ürün
Special Coverage
Blog
Dec 27, 2024, 18:27
A CRISPR-based rapid molecular diagnostic for two forms of leukemia - Dana-Farber Cancer Institute
Blog
Dec 27, 2024, 18:15
Cancer Fashionista, a platform that empowers thousands of patients and survivors - Conquer Cancer, the ASCO Foundation
Insight
Dec 27, 2024, 18:12
James Crowley: For a growing number of bacterial pathogens, the success rate of antibiotics is iffy
Insight
Dec 27, 2024, 17:53
The first round of chemotherapy in high-risk neuroblastoma patients - St. Baldrick's Foundation
Blog
Dec 27, 2024, 17:38
Long-Term Follow-Up and Overall Survival in NRG258 by Daniela E Matei et al.
Blog
Dec 27, 2024, 17:35
Rahul Gosain: CLL Highlights with John Allan
Insight
Dec 27, 2024, 17:30
Vivek Subbiah: An overview of AI methods designed to detect cancer early
Blog
Dec 27, 2024, 17:29
Almost all cancer treatments used in children today were actually developed for adults - Children's Cancer Institute
Blog
Dec 27, 2024, 17:27
Promising Efficacy and Controllable Safety of CD7 CAR-T Cell Therapy in Treating R/R PTCL - MediaMedic
Insight
Dec 27, 2024, 17:25
HTA recommendations on coverage and reimbursement for cancer medicines
Blog
Dec 27, 2024, 17:25
Habib Nehmé: Reflecting on the past and looking forward to the future
Blog
Dec 27, 2024, 17:16
Arif Kamal: The Hope Lodge Communities at ACS are a jewel in our crown